The staphylococcal enterotoxin serotype B (SEB)-induced enteric intoxication and the immediate-type reaction in the skin of unsensitized monkeys was used to define whether agents competing with SEB for target cell receptors may inhibit pathophysiological effects. For this purpose a duodenal provocation test was developed by use of a pediatric gastroscope, allowing the evaluation of the influence of antagonists on the intestinal disorder upon SEB challenge at the same duodenal site. First, carboxymethylation of histidine residues of SEB caused a complete loss of emetic and skinsensitizing activity without changing the immunological specificity. However, carboxymethylated SEB is a strong inhibitor of enteric intoxications and immediate-type skin reactions upon SEB challenge. Second, after immunization of BALB/c mice with monoclonal anti-SEB antibodies, monoclonal antiidiotypic antibodies (anti-Id) were obtained by the "hybridoma technique" and purification by idiotype-affinity chromatography. Anti-Id specifically inhibited the binding of horseradish peroxidase-labeled anti-SEB to the ligand, and SEB blocked as well the interaction of these two antibody species, indicating a high degree of binding-site selectivity. Anti-Id completely protected against emetic response and diarrhea upon duodenal provocation with SEB and inhibited immediate-type skin reactions as well. Further, anti-Id acted as an antagonist without triggering biologic functions themselves. This shows that anti-Id constitute a useful tool to protect against a bacterial toxininduced intestinal disorder.
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Staphylococcal enterotoxins (SE) are responsible for one of the most common types of food poisoning in humans (1) . All SE produce emesis and diarrhea in humans and other primates as a result of oral administration, whereas the toxin appears to have little, if any, clinical effect in other laboratory animals (1) . Although considerable efforts have been expended on attempts to define the pathogenesis, so far very little information has been available on the mode and cellular site of SE action in the gastrointestinal tract. Recently, however, evidence was provided that unsensitized monkeys develop an immediate-type reaction in the skin upon intradermal challenge with SE serotype B (SEB; ref. 2) . As shown by a series of experiments, SEB administered intradermally causes skin reactions by affecting mast cells (2) . This type of nonimmunological mast cell stimulation by SEB offered a new approach, providing a model for investigating the mechanisms of SEB action. In addition, evidence was provided that carboxymethylation of SEB resulted in a loss of toxicity associated with the complete abrogation of skin-sensitizing activity without changing the immunological specificity of the toxin. It has been established that carboxymethylated SEB (CM-SEB) could compete with SEB for binding sites on the target-cell surface (2) . To define whether SEB exerts its effect on mast cells by binding to specific celt-surface receptors or whether a less specific type of ligand-cell membrane interaction is involved, we have focused attention on the functional aspects of anti-receptor antibodies induced through the antiidiotypic route as a useful tool to recognize receptors on the target cell membrane.
Such an approach has already been successfully applied with hormones in the identification of insulin receptors (3) and 8-adrenergic receptors (4), respectively, on cell membranes. In a first series of experiments (5), some of us demonstrated that polyclonal anti-idiotypic antibodies (antiId) with a high degree of binding-site selectivity raised in BALB/c mice against monoclonal anti-SEB antibodies (anti-SEB) completely antagonize immediate-type reactions in the skin of unsensitized monkeys. Since differences may exist in the response of the skin and the gastrointestinal tract to SEB in the monkey, the relevance of the skin test data is unclear. To gain a better understanding of the mechanisms underlying SEB-induced enteric intoxication, we therefore performed duodenal provocation tests with SEB via a pediatric gastroscope to define the influence of CM-SEB and of anti-Id on the intestinal disorder. In this context, the use of monoclonal rather than polyclonal anti-Id was preferred to ensure a stable source of antibodies with a single activity and availability in large quantities. We will demonstrate that CM-SEB and monoclonal anti-Id, the latter even in the picomolar range, completely protected against emetic response and diarrhea in the monkey following SEB challenge. This is the evidence for complete protection against a toxin-induced intestinal disorder by anti-Id in primates. (6) . BALB/c (H-2d) mice were obtained from our own breeding stock, maintained on standard diet and water ad libitum, and used routinely at age 6-8 weeks.
MATERIALS AND METHODS
Toxin. SEB was highly purified by the method described previously (7) . To prepare CM-SEB, the procedure of Harris and Hill (8) (10) and were purified by affinity chromatography as described by Bamberger et al. (5) . Polyclonal anti-Id, with specificity against the binding sites of anti-SEB, were prepared and purified by published methods (5) . For production of monoclonal anti-Id, BALB/c mice primed with dinitrophenyl-substituted ovalbumin were immunized with monoclonal anti-SEB lightly substituted with dinitrophenyl by the method of Schuler et al. (11) with slight modifications (12) . Finally the mice were rechallenged 4, 3, and 2 days before sacrifice with 100 ,ug i.p. of dinitrophenylsubstituted anti-SEB. Splenic lymphocytes (1 x 108) from one immunized mouse were fused with 2 x 107 P3X63-Ag8.653 mouse myeloma cells by standard techniques (10) as described in detail (5) . Supernatants of hybridoma were screened for anti-Id in inhibition enzyme immunoassay.
After the cloning and recloning of selected hybridomas by limiting dilution, pristane-pretreated BALB/c mice were injected i.p. with 1 x 10 to 2 x 107 cells in 0.5 ml of phosphate-buffered saline (10 mM sodium phosphate/140 mM NaCl, pH 7.2; PBS).
Purification of Monoclonal Anti-Id. The IgG-enriched fraction of anti-Id was obtained from ascitic fluid by precipitation with 2 M ammonium sulfate and subsequently absorbed with preimmune BALB/c IgG cross-linked to Eupergit C following approved techniques (5). Finally, anti-Id was purified by elution from a monoclonal anti-SEB-Eupergit C column (5) . Isotyping of purified anti-Id by ELISA using subclass-specific antisera yielded antibodies of the IgG1K isotype.
The preparation of F(ab')2 fragments from monoclonal anti-Id used in this study has been described by Parham (13 provocation tests were performed in unsensitized monkeys in the last 10 min of a 30-min anesthesia (11 mg of ketamine hydrochloride i.m. per kg of body weight) by use of a pediatric gastroscope (GIF-P10, Olympus, Munich). In a few cases, the animals were challenged with 0.1 ml of either 5 ,M SEB or 25 ,uM CM-SEB, respectively, or with a mixture of both (0.1 ml total) at a molar ratio of 1:5 by injection into the duodenal mucosa with a sclerotherapy needle (diameter 0.18 mm) as shown in Fig. 1 . In general, however, to study the anti-Id effect, purified anti-Id, anti-SEB, or preimmune IgG were added to SEB at different molar ratios and applied onto the mucosal surface of the duodenum via a plastic tube (inside diameter, 0.18 mm). In addition, the persistence of these antibodies on target cell receptors was evaluated by their administration onto the mucosal surface 24 hr before challenge with SEB on the same site in the descending part of the duodenum, =1.5 cm below the papilla of Vater. To mark the duodenal site precisely for an additional application of agents, a biopsy was taken immediately beneath the original application site. The clinical course was followed for a period of 24 hr. RESULTS Carboxymethylation of SEB. The rate of carboxymethylation of SEB was similar to that observed by Harris and Hill (8) and specific for histidine residues under the conditions used. Alkylation proceeds in 14 days to such an extent that the six histidine residues present in our SEB preparation (7) were derivatized to carboxymethylhistidine. This chemical modification of SEB caused a conversion from alkaline components to more acid species and an increase in microheterogeneity (2) .
By testing CM-SEB for biological activity, it could be shown that the modification of six histidine residues caused a total loss in toxicity of the molecule.
Specificity of Anti-Id. The Effect of CM-SEB on SEB-Induced Reactions. Previous studies (2) have indicated that CM-SEB could compete with SEB for binding on the target-cell surface in the skin of unsensitized monkeys. From the data in Fig. 3 , it is apparent that SEB promoted immediate-type skin reactions, whereas CM-SEB consistently failed to do so, even when tested at doses up to 100 1LM. However, immediate-type skin reactions were completely inhibited in the presence of CM-SEB when used at a 5 x molar excess.
Further, we examined the possibility that CM-SEB might be a useful tool to influence the SEB-induced intestinal Skin reaction,mm diameter cSEB SEB Proc. Natl. Acad. Sci. USA 8S (1988) 3173 disorder. Indeed, the data in Fig. 3 show clearly that CM-SEB administered intraduodenally completely protected against emetic response and diarrhea after challenge with SEB when used at a 5:1 molar ratio.
Effect of Anti-Id on SEB-Induced Reactions. To examine whether the monoclonal anti-Id reacts with the ligand binding site on the target cell surface, we first tested its effect on the SEB-induced immediate-type skin reaction. In this context, increasing concentrations of anti-Id were used to compete with the action of SEB at different SEB doses (0.1-2.5 ,uM). Anti-Id at 1 pM to 1 nM impedes the immediate-type reaction in the skin of unsensitized monkeys in a concentration-dependent manner (Fig. 4) Since some of us have reported (5) inhibitory capacity of anti-SEB as well on SEB-induced immediate-type skin reactions, the effect of these antibodies was assessed on the enteric intoxication. From the results it is clear that anti-SEB has inhibitory activity, but it is less potent than that of anti-Id (data not shown).
From the data presented in Table 1 , it should be expected that anti-Id reacts with the target cell receptor in the intes- 
DISCUSSION
The impetus for these studies arose from the observation that SEB provokes an immediate-type reaction in the skin of unsensitized monkeys that could be completely inhibited in the presence of CM-SEB or polyclonal anti-Id (2, 5). Therefore, it was certainly reasonable to expect that CM-SEB and the anti-Id reagent might act as antagonists of the toxin and as such would block the intestinal disorder upon challenge with SEB as well. To dissect these effects on the intestinal (duodenal) level, the use of a monoclonal anti-Id as a stable source of antibodies with a single activity would be of considerable advantage.
In the first part of this study, we report the preparation and characterization of CM-SEB and monoclonal anti-Id, the latter generated against monoclonal anti-SEB by the hybridoma technique. The detoxification of SEB was based on the finding that carboxymethylation of SE type A resulted in a loss of toxicity without changing immunological specificity (15) . A corresponding treatment of SEB with bromoacetate at pH 7.0 for 14 days derivatized all histidine residues and abrogated the toxicity completely.
The monoclonal anti-Id of the IgGlK isotype induced against monoclonal anti-SEB was purified by idiotype affinity chromatography. Before testing, anti-Id was sequentially absorbed on preimmune BALB/c IgG and SEB to remove any anti-isotypic or anti-SEB antibodies that could interfere with our tests. That anti-Id specific for the binding site of monoclonal anti-SEB may act as an internal image of the toxin was substantiated by showing that monoclonal anti-Id, even at picomolar concentrations, competed with SEB for binding to HRP-conjugated anti-SEB in a dose-dependent fashion. Its inhibiting capacity was much greater than that of a polyclonal anti-Id generated previously (5) , suggesting that only a small fraction of the latter antibody molecules function as the immunological internal image of SEB. The reaction between solid-phase anti-Id and HRP-conjugated anti-SEB was also blocked in a dose-dependent manner by the SEB ligand, indicating a high degree of binding site selectivity. The specificity of anti-Id was further demonstrated by its inability L. to compete with the binding of monoclonal antibodies to heat-killed Listeria monocytogenes.
Most important in this study was the development of a duodenal provocation test by use of a pediatric gastroscope in the monkey, allowing the evaluation of the influence of CM-SEB and of anti-Id on the intestinal disorder upon SEB challenge at the same duodenal site. In this context it has to be stated that the animals showed no reaction on the duodenal mucosa by this technique. We have presented detailed evidence for the failure of CM-SEB to elicit enteric intoxication and immediate-type reactions in the skin of unsensitized monkeys. It is apparent from the results, however, that in fact CM-SEB specifically inhibits the response to SEB in skin sites. Correspondingly, CM-SEB injected in combination with SEB into the duodenal mucosa completely protected against emetic response and diarrhea when used at a 5 x molar excess. The data strongly support the view that CM-SEB competes with SEB for the binding to target-cell receptors. That SEB may act by affecting mast cells is reflected in the ultrastructural morphology of these cells at sites of skin reactions (2) . So far, however, it has not been delineated whether skin mast cells are activated for mediator release in a direct or indirect way. Recent studies, however, have clearly indicated that cysteinyl leukotrienes are important mediators in the pathophysiology of the SEB-induced enteric intoxication (16) . Moreover, evidence was provided that excretion of intestinal leukotriene metabolites with stool competes with their enterohepatic circulation (17) . Since the observation by Sege and Peterson that anti-Id against antiinsulin induces a physiological response (3), several reports have demonstrated antagonistic effects of anti-Id rds well (18, 19) . Of particular importance, therefore, was the finding that anti-Id indeed, but not preimmune IgG, was highly efficient in inhibiting immediate-type skin reactions. Comparison of the inhibitory capacity of polyclonal (5) and monoclonal anti-Id indicated that the latter was 103-fold stronger. Inhibition was also observed when anti-SEB was substituted for anti-Id, but the former was less efficient. The most striking of our findings was the observation that 100 pM anti-Id applied onto the mucosal surface of the duodenum completely protected against emetic response and diarrhea when challenged with SEB at the same duodenal site. Monkeys whose duodenal sites were exposed to 1000 pM anti-Id 24 hr before SEB became totally unresponsive as well. Most notable is the fact that only picomolar concentrations of anti-Id are required to compete with 103-to 104-fold higher concentrations of SEB for binding to its receptor. Further, anti-Id did not inhibit immediate-type skin reactions mediated by IgE antibody or induced with 48/80, demonstrating its specificity. However, treatment of duodenal sites with anti-SEB 24 hr before challenge with the toxin lacked any inhibitory capacity. This is in keeping with corresponding studies in the skin of the monkey. Further, the findings provide evidence that at least some amount of anti-Id is passing the duodenal barrier without being seriously degraded. At least in the monkey system used, the anti-Id acts exclusively as antagonist of SEB and as such will block the binding of the natural ligand and also inhibit the toxic effects.
That anti-Id, even at the picomolar range, exerts a prolonged blocking effect on the intestinal intoxication promoted by SEB indicates a considerable affinity and persistence of anti-Id at binding sites on target cells in the intestinal mucosa. Whether the receptors recognized by anti-Id are SEB-specific cannot at present be answered because at least polyclonal anti-Id also impeded the immediate-type skin reaction provoked by SE type A and C1 (5) . Whether this is secondary to the action of anti-Id at a site other than that which binds SEB is not clear. However, it cannot be excluded that several SE receptors may actually exist on the surface of cutaneous mast cells in the cynomolgus monkey. There is some indication that mucosal mast cells might be the targets for SEB in the intestinal mucosa, but one has to define whether the toxin effects the mediator release by acting directly on these cells. Alternatively, mast cell secretion may also be mediated by neuropeptides released from peripheral terminals of sensory nerve fibers (20) upon stimulation with SEB.
We presented here evidence that a monoclonal anti-Id against monoclonal anti-SEB displays the characteristics of a competitive antagonist and as such will protect against the intestinal disorder upon challenge with a bacterial exotoxin. Therefore, monoclonal anti-Id able to recognize SEBspecific receptors may be regarded as an original and promising tool to protect against SEB-provoked enteric intoxications. Further, by using the anti-Id approach, internal images of bacterial toxins could be produced, and this concept may be applied to the detection and characterization of specific receptors on the targets in the intestinal mucosa.
